Astec Lifesciences Ltd Announces Board Meeting to Review Q1 Unaudited Financial Results
Astec LifeSciences Ltd has scheduled a meeting of its Board of Directors to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ending June 30, 2026.The Board meeting is set to be held on Friday, July 31, 2026.
During the meeting, the company will review the aforementioned financial results. A key prerequisite for this approval process is that the Standalone and Consolidated Unaudited Financial Results must first be reviewed by the Audit Committee of Astec LifeSciences Limited.
ASTEC Stock Price Movement
Today, shares of Astec LifeSciences Limited tumbled by 2.31%, finishing the session at ₹678.50 following a drop of ₹15.85 from yesterday's close. The stock traded within an intraday range of ₹668.10 to ₹690.00, with a reported volume of 68,037 shares in the post-market trade.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.